Literature DB >> 8774148

Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm).

M J Gijbels1, C Zurcher, G Kraal, G R Elliott, H HogenEsch, G Schijff, H F Savelkoul, P L Bruijnzeel.   

Abstract

Chronic proliferative dermatitis is a spontaneous mutation in C57BL/Ka mice (cpdm/cpdm), showing alopecia, epithelial hyperproliferation, infiltration by eosinophils and macrophages, and vascular dilatation. To further elucidate its pathogenesis, organs of 1-, 2-, 3-, 4-, 5-, and 6-week-old cpdm/cpdm mice were examined. At 4 weeks, the epidermal thickness was increased, whereas already at 3 weeks, the bromodeoxyuridine incorporation was increased in the basal keratinocytes. However, already at the age of 1 week, skin, lungs, and lymph nodes were infiltrated by eosinophils although no macroscopic lesions were present. Compared with control animals, 6-week-old cpdm/cpdm mice had decreased serum IgE levels and increased numbers of mast cells. From the age of 1 week these mast cells became increasingly IgE positive. In contrast, the mast cells of the control animals remained IgE negative. Mast cells of control and cpdm/cpdm mice were interleukin-4 and tumor necrosis factor-alpha positive. A likely explanation for the tissue infiltration of eosinophils could be the release of interleukin-4 and tumor necrosis factor-alpha from activated mast cells. Tumor necrosis factor-alpha may lead to the expression of E-selectin on endothelial cells, facilitating interleukin-4-mediated eosinophil transendothelial migration. Although various pathogenetic aspects of the cpdm/cpdm mouse need further elucidation, this model can be a tool to study eosinophil infiltration, leukocyte-endothelial cell interactions, and mast cell proliferation. Furthermore, the cpdm/cpdm mouse can be used to study chronic inflammatory skin disease because of the severe epidermal proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774148      PMCID: PMC1861706     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo.

Authors:  U Gotsch; U Jäger; M Dominis; D Vestweber
Journal:  Cell Adhes Commun       Date:  1994-04

Review 2.  For better or for worse: does stem cell factor importantly regulate mast cell function in pulmonary physiology and pathology?

Authors:  S J Galli; B K Wershil; J J Costa; M Tsai
Journal:  Am J Respir Cell Mol Biol       Date:  1994-12       Impact factor: 6.914

Review 3.  RANTES, a novel eosinophil-chemotactic cytokine.

Authors:  J M Schröder; Y Kameyoshi; E Christophers
Journal:  Ann N Y Acad Sci       Date:  1994-05-28       Impact factor: 5.691

4.  Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE.

Authors:  M Baniyash; Z Eshhar
Journal:  Eur J Immunol       Date:  1984-09       Impact factor: 5.532

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  IgE receptors on human basophils. Relationship to serum IgE concentration.

Authors:  F J Malveaux; M C Conroy; N F Adkinson; L M Lichtenstein
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

7.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma.

Authors:  R L Coffman; J Carty
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

8.  Ultrastructure of epidermis of mice with chronic proliferative dermatitis.

Authors:  M J Gijbels; H HogenEsch; B Blauw; P Roholl; C Zurcher
Journal:  Ultrastruct Pathol       Date:  1995 Mar-Apr       Impact factor: 1.094

9.  Maintenance of donor phenotype after full-thickness skin transplantation from mice with chronic proliferative dermatitis (cpdm/cpdm) to C57BL/Ka and nude mice and vice versa.

Authors:  M J Gijbels; H HogenEsch; P L Bruijnzeel; G R Elliott; C Zurcher
Journal:  J Invest Dermatol       Date:  1995-12       Impact factor: 8.551

10.  Only simultaneous blocking of the L- and P-selectin completely inhibits neutrophil migration into mouse peritoneum.

Authors:  R Bosse; D Vestweber
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

View more
  20 in total

1.  Differential Involvement of the Npl4 Zinc Finger Domains of SHARPIN and HOIL-1L in Linear Ubiquitin Chain Assembly Complex-Mediated Cell Death Protection.

Authors:  Satoshi Shimizu; Hiroaki Fujita; Yoshiteru Sasaki; Tatsuaki Tsuruyama; Kazuhiko Fukuda; Kazuhiro Iwai
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

2.  Inhibition of NF-κB signaling retards eosinophilic dermatitis in SHARPIN-deficient mice.

Authors:  Yanhua Liang; Rosemarie E Seymour; John P Sundberg
Journal:  J Invest Dermatol       Date:  2010-09-02       Impact factor: 8.551

3.  Linear polyubiquitin chains: a new modifier involved in NFκB activation and chronic inflammation, including dermatitis.

Authors:  Kazuhiro Iwai
Journal:  Cell Cycle       Date:  2011-09-15       Impact factor: 4.534

4.  Loss-of-function of SHARPIN causes an osteopenic phenotype in mice.

Authors:  Tian Xia; Yanhua Liang; Junrong Ma; Mi Li; Meng Gong; Xijie Yu
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

Review 5.  The Regulation and Modification of GSDMD Signaling in Diseases.

Authors:  Zihao Li; Senlin Ji; Mei-Ling Jiang; Yun Xu; Cun-Jin Zhang
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

6.  The pathogenesis of chronic eosinophilic esophagitis in SHARPIN-deficient mice.

Authors:  Syu-Jhe Chien; Kathleen A Silva; Victoria E Kennedy; Harm HogenEsch; John P Sundberg
Journal:  Exp Mol Pathol       Date:  2015-08-29       Impact factor: 3.362

7.  Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.

Authors:  Matthew L Renninger; Rosemarie E Seymour; Laurence O Whiteley; John P Sundberg; Harm Hogenesch
Journal:  Exp Dermatol       Date:  2009-07-23       Impact factor: 3.960

Review 8.  SHARPIN is a key regulator of immune and inflammatory responses.

Authors:  Zhe Wang; Christopher S Potter; John P Sundberg; Harm Hogenesch
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

9.  Chronic Proliferative Dermatitis in Mice: NFκB Activation Autoinflammatory Disease.

Authors:  Yanhua Liang
Journal:  Patholog Res Int       Date:  2011-06-01

10.  Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes.

Authors:  Sabrina Sieber; Nicole Lange; Gwendlyn Kollmorgen; Annette Erhardt; Alexander Quaas; Arthur Gontarewicz; Gabriele Sass; Gisa Tiegs; Hans-Jürgen Kreienkamp
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.